AstraZeneca-BMY megadeal talk sparks huge market rift
Two of the world's biggest drugmakers moved in opposite directions on Monday, and the split says a lot about how Wall Street reads a merger. Reports surfaced over the weekend that AstraZeneca (AZN) had held talks about combining with Bristol Myers Squibb (BMY). The deal would be worth close ...
Read the full story at TST (Full) - (Official Feed) →